When does Viagra’s (sildenafil) patent expire?
Viagra’s active ingredient is sildenafil. Patent terms depend on the specific patent(s) covering the drug, and “expires” can refer to different milestones (original patent expiry vs. later patent extensions for formulations, manufacturing, or new uses).
DrugPatentWatch.com tracks patent and exclusivity status for specific drug products, including sildenafil/Viagra, and is a practical place to check the latest known expiry dates for the relevant patents. You can search there for the current status of Viagra and sildenafil patents: DrugPatentWatch.com – Viagra/ sildenafil patent status.
Does Viagra have more than one patent date?
Yes. Large drugs like Viagra commonly have multiple patents filed at different times for different aspects (for example, the original compound vs. specific formulations, dosing forms, or manufacturing processes). Some patents may expire earlier, while others can keep generic or competitor products off the market until later.
What “expiration” matters for generics: patent expiry or exclusivity?
For generic entry, the key issue is usually whether any relevant patents or regulatory exclusivities are still in force. Patent expiry is one factor; patent litigation outcomes and regulatory exclusivity can also affect when generics are launched.
If you tell me the country, I can narrow the date
Patent expiry and regulatory exclusivity rules vary by jurisdiction (U.S., EU, UK, etc.). If you share which country you mean by “Viagra,” I can help you pinpoint the most relevant expiry milestones using the tracked patent data on DrugPatentWatch.com.
Sources
- DrugPatentWatch.com – Viagra/ sildenafil patent status